Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2024-2028

Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2024-2028


The duchenne muscular dystrophy (DMD) therapeutics market is forecasted to grow by USD 4373.3 mn during 2023-2028, accelerating at a CAGR of 28.21% during the forecast period. The report on the duchenne muscular dystrophy (DMD) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high unmet need for duchenne muscular dystrophy therapeutics, increasing strategic alliances among the vendors, and introduction of patient assistance programs.

Technavio's duchenne muscular dystrophy (DMD) therapeutics market is segmented as below:
  • By Type
  • Biologics
  • Small molecules
  • By Distribution Channel
  • Offline
  • Online
  • By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the strong pipeline for duchenne muscular dystrophy therapeutics as one of the prime reasons driving the duchenne muscular dystrophy (DMD) therapeutics market growth during the next few years. Also, increasing research funding for duchenne muscular dystrophy therapeutics and special drug designation for duchenne muscular dystrophy (DMD) therapeutics will lead to sizable demand in the market.

The report on the duchenne muscular dystrophy (DMD) therapeutics market covers the following areas:
  • Duchenne muscular dystrophy (DMD) therapeutics market sizing
  • Duchenne muscular dystrophy (DMD) therapeutics market forecast
  • Duchenne muscular dystrophy (DMD) therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading duchenne muscular dystrophy (DMD) therapeutics market vendors that include BioMarin Pharmaceutical Inc., Capricor Therapeutics Inc., CRISPR Therapeutics AG, CVS Health Corp., Daiichi Sankyo Co. Ltd., Editas Medicine Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., FibroGen Inc., Italfarmaco Holding SPA, Nippon Shinyaku Co. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., PTC Therapeutics Inc., Santhera Pharmaceuticals Holding AG, Sarepta Therapeutics Inc., The Cleveland Clinic Foundation, Vertex Pharmaceuticals Inc., and Wave Life Sciences Ltd.. Also, the duchenne muscular dystrophy (DMD) therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Biologics - Market size and forecast 2023-2028
Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Chart on Biologics - Year-over-year growth 2023-2028 (%)
Data Table on Biologics - Year-over-year growth 2023-2028 (%)
6.4 Small molecules - Market size and forecast 2023-2028
Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
Chart on Small molecules - Year-over-year growth 2023-2028 (%)
Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2023-2028
Chart on Offline - Market size and forecast 2023-2028 ($ million)
Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Chart on Offline - Year-over-year growth 2023-2028 (%)
Data Table on Offline - Year-over-year growth 2023-2028 (%)
7.4 Online - Market size and forecast 2023-2028
Chart on Online - Market size and forecast 2023-2028 ($ million)
Data Table on Online - Market size and forecast 2023-2028 ($ million)
Chart on Online - Year-over-year growth 2023-2028 (%)
Data Table on Online - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. - Overview
BioMarin Pharmaceutical Inc. - Product / Service
BioMarin Pharmaceutical Inc. - Key offerings
12.4 Capricor Therapeutics Inc.
Capricor Therapeutics Inc. - Overview
Capricor Therapeutics Inc. - Product / Service
Capricor Therapeutics Inc. - Key offerings
12.5 CRISPR Therapeutics AG
CRISPR Therapeutics AG - Overview
CRISPR Therapeutics AG - Product / Service
CRISPR Therapeutics AG - Key offerings
12.6 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product / Service
Daiichi Sankyo Co. Ltd. - Key news
Daiichi Sankyo Co. Ltd. - Key offerings
12.7 Editas Medicine Inc.
Editas Medicine Inc. - Overview
Editas Medicine Inc. - Product / Service
Editas Medicine Inc. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.9 Italfarmaco Holding SPA
Italfarmaco Holding SPA - Overview
Italfarmaco Holding SPA - Product / Service
Italfarmaco Holding SPA - Key offerings
12.10 Nippon Shinyaku Co. Ltd.
Nippon Shinyaku Co. Ltd. - Overview
Nippon Shinyaku Co. Ltd. - Business segments
Nippon Shinyaku Co. Ltd. - Key offerings
Nippon Shinyaku Co. Ltd. - Segment focus
12.11 Otsuka Holdings Co. Ltd.
Otsuka Holdings Co. Ltd. - Overview
Otsuka Holdings Co. Ltd. - Business segments
Otsuka Holdings Co. Ltd. - Key news
Otsuka Holdings Co. Ltd. - Key offerings
Otsuka Holdings Co. Ltd. - Segment focus
12.12 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.13 PTC Therapeutics Inc.
PTC Therapeutics Inc. - Overview
PTC Therapeutics Inc. - Product / Service
PTC Therapeutics Inc. - Key offerings
12.14 Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG - Overview
Santhera Pharmaceuticals Holding AG - Product / Service
Santhera Pharmaceuticals Holding AG - Key offerings
12.15 Sarepta Therapeutics Inc.
Sarepta Therapeutics Inc. - Overview
Sarepta Therapeutics Inc. - Product / Service
Sarepta Therapeutics Inc. - Key offerings
12.16 The Cleveland Clinic Foundation
The Cleveland Clinic Foundation - Overview
The Cleveland Clinic Foundation - Product / Service
The Cleveland Clinic Foundation - Key offerings
12.17 Wave Life Sciences Ltd.
Wave Life Sciences Ltd. - Overview
Wave Life Sciences Ltd. - Product / Service
Wave Life Sciences Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Type - Market share 2023-2028 (%)
Exhibits33: Data Table on Type - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Type
Exhibits35: Data Table on Comparison by Type
Exhibits36: Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Small molecules - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Type ($ million)
Exhibits45: Data Table on Market opportunity by Type ($ million)
Exhibits46: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits47: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Distribution Channel
Exhibits49: Data Table on Comparison by Distribution Channel
Exhibits50: Chart on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Online - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Online - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits58: Market opportunity by Distribution Channel ($ million)
Exhibits59: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits103: Impact of drivers and challenges in 2023 and 2028
Exhibits104: Overview on criticality of inputs and factors of differentiation
Exhibits105: Overview on factors of disruption
Exhibits106: Impact of key risks on business
Exhibits107: Companies covered
Exhibits108: Matrix on companies position and classification
Exhibits109: BioMarin Pharmaceutical Inc. - Overview
Exhibits110: BioMarin Pharmaceutical Inc. - Product / Service
Exhibits111: BioMarin Pharmaceutical Inc. - Key offerings
Exhibits112: Capricor Therapeutics Inc. - Overview
Exhibits113: Capricor Therapeutics Inc. - Product / Service
Exhibits114: Capricor Therapeutics Inc. - Key offerings
Exhibits115: CRISPR Therapeutics AG - Overview
Exhibits116: CRISPR Therapeutics AG - Product / Service
Exhibits117: CRISPR Therapeutics AG - Key offerings
Exhibits118: Daiichi Sankyo Co. Ltd. - Overview
Exhibits119: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits120: Daiichi Sankyo Co. Ltd. - Key news
Exhibits121: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits122: Editas Medicine Inc. - Overview
Exhibits123: Editas Medicine Inc. - Product / Service
Exhibits124: Editas Medicine Inc. - Key offerings
Exhibits125: F. Hoffmann La Roche Ltd. - Overview
Exhibits126: F. Hoffmann La Roche Ltd. - Business segments
Exhibits127: F. Hoffmann La Roche Ltd. - Key news
Exhibits128: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits129: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits130: Italfarmaco Holding SPA - Overview
Exhibits131: Italfarmaco Holding SPA - Product / Service
Exhibits132: Italfarmaco Holding SPA - Key offerings
Exhibits133: Nippon Shinyaku Co. Ltd. - Overview
Exhibits134: Nippon Shinyaku Co. Ltd. - Business segments
Exhibits135: Nippon Shinyaku Co. Ltd. - Key offerings
Exhibits136: Nippon Shinyaku Co. Ltd. - Segment focus
Exhibits137: Otsuka Holdings Co. Ltd. - Overview
Exhibits138: Otsuka Holdings Co. Ltd. - Business segments
Exhibits139: Otsuka Holdings Co. Ltd. - Key news
Exhibits140: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits141: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits142: Pfizer Inc. - Overview
Exhibits143: Pfizer Inc. - Product / Service
Exhibits144: Pfizer Inc. - Key news
Exhibits145: Pfizer Inc. - Key offerings
Exhibits146: PTC Therapeutics Inc. - Overview
Exhibits147: PTC Therapeutics Inc. - Product / Service
Exhibits148: PTC Therapeutics Inc. - Key offerings
Exhibits149: Santhera Pharmaceuticals Holding AG - Overview
Exhibits150: Santhera Pharmaceuticals Holding AG - Product / Service
Exhibits151: Santhera Pharmaceuticals Holding AG - Key offerings
Exhibits152: Sarepta Therapeutics Inc. - Overview
Exhibits153: Sarepta Therapeutics Inc. - Product / Service
Exhibits154: Sarepta Therapeutics Inc. - Key offerings
Exhibits155: The Cleveland Clinic Foundation - Overview
Exhibits156: The Cleveland Clinic Foundation - Product / Service
Exhibits157: The Cleveland Clinic Foundation - Key offerings
Exhibits158: Wave Life Sciences Ltd. - Overview
Exhibits159: Wave Life Sciences Ltd. - Product / Service
Exhibits160: Wave Life Sciences Ltd. - Key offerings
Exhibits161: Inclusions checklist
Exhibits162: Exclusions checklist
Exhibits163: Currency conversion rates for US$
Exhibits164: Research methodology
Exhibits165: Information sources
Exhibits166: Data validation
Exhibits167: Validation techniques employed for market sizing
Exhibits168: Data synthesis
Exhibits169: 360 degree market analysis
Exhibits170: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings